Literature DB >> 9781356

The gut. A key metabolic organ protected by lactoferrin during experimental systemic inflammation in mice.

M L Kruzel1, Y Harari, C Y Chen, G A Castro.   

Abstract

The gastrointestinal tract may be viewed as an ecologic system in which a balance between the host and bacterial flora exists. Two major host components appear to be involved in maintaining this balance. The first is a non-specific structural barrier provided by the epithelial layer of the gastrointestinal mucosae. The second component involves functional immunological elements found in the mucosal and submucosal compartments, e.g., gut associated lymphoid tissue. When gut integrity is disrupted by invasive pathogens or by trauma, a myriad of pro-inflammatory mediators are released from cells in the gut wall that exert actions in the tissue or gut lumen. One of these mediators is lactoferrin, and iron binding protein found in high concentration in most human exocrine secretions. Despite controversies on its physiological role, evidence is emerging that lactoferrin plays an important role in host defense against toxic metabolites and antigenic components of potential pathogens2-4. This manuscript is intended to provide an overview of work related to lactoferrin's modulatory roles in inflammation, and to present observations from experimental studies on the preservation of intestinal structure and function by lactoferrin during intestinal inflammation. The possibility that lactoferrin limits the autodestructive inflammatory responses presents a new alternative for the future management of systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781356

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

1.  Lactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response.

Authors:  Kerry J Welsh; Shen-An Hwang; Robert L Hunter; Marian L Kruzel; Jeffrey K Actor
Journal:  Transl Res       Date:  2010-06-30       Impact factor: 7.012

2.  Cloning of a pig homologue of the human lactoferrin receptor: expression and localization during intestinal maturation in piglets.

Authors:  Yalin Liao; Veronica Lopez; Tracy B Shafizadeh; Charles H Halsted; Bo Lönnerdal
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2007-08-08       Impact factor: 2.320

3.  Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice.

Authors:  M L Kruzel; Y Harari; D Mailman; J K Actor; M Zimecki
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

4.  Towards an understanding of biological role of colostrinin peptides.

Authors:  M L Kruzel; M Janusz; J Lisowski; R V Fischleigh; J A Georgiades
Journal:  J Mol Neurosci       Date:  2001-12       Impact factor: 3.444

Review 5.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 6.  Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous Pathology.

Authors:  Jeffrey K Actor
Journal:  Mediators Inflamm       Date:  2015-12-14       Impact factor: 4.711

Review 7.  Clinical Potential of Hyperbaric Pressure-Treated Whey Protein.

Authors:  André F Piccolomini; Stan Kubow; Larry C Lands
Journal:  Healthcare (Basel)       Date:  2015-06-19

8.  No Difference in Lactoferrin Levels between Metabolically Healthy and Unhealthy Obese Women.

Authors:  Małgorzata Jamka; Patrycja Krzyżanowska-Jankowska; Edyta Mądry; Aleksandra Lisowska; Paweł Bogdański; Jarosław Walkowiak
Journal:  Nutrients       Date:  2019-08-22       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.